Its aberrant elevation has been strongly linked to depression (29), and minocycline—a tetracycline antibiotic and MMP-9 inhibitor—has been proposed as a therapeutic agent for depressive symptoms (30, 31). The gene discussed is MMP9; the disease is major depressive disorder.